Agreement expands Active Motif’s research genomics portfolio while supporting Arima’s strategic focus on its clinical diagnostics platform CARLSBAD, Calif., July 6, 2026 /PRNewswire/ — Active Motif, a leading provider of epigenetics and multiomic solutions to mechanistic, translational,…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
